Alan C. Cameron

1.4k total citations · 1 hit paper
31 papers, 756 citations indexed

About

Alan C. Cameron is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, Alan C. Cameron has authored 31 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 14 papers in Epidemiology and 6 papers in Molecular Biology. Recurrent topics in Alan C. Cameron's work include Acute Ischemic Stroke Management (13 papers), Atrial Fibrillation Management and Outcomes (9 papers) and Chemotherapy-induced cardiotoxicity and mitigation (6 papers). Alan C. Cameron is often cited by papers focused on Acute Ischemic Stroke Management (13 papers), Atrial Fibrillation Management and Outcomes (9 papers) and Chemotherapy-induced cardiotoxicity and mitigation (6 papers). Alan C. Cameron collaborates with scholars based in United Kingdom, Canada and Switzerland. Alan C. Cameron's co-authors include Rhian M. Touyz, Ninian N. Lang, Jesse Dawson, Terence J. Quinn, Kennedy R. Lees, Azmil H. Abdul‐Rahim, Francisco J. Rios, Augusto C. Montezano, Janika Kõrv and Karla B Neves and has published in prestigious journals such as Neurology, Stroke and Hypertension.

In The Last Decade

Alan C. Cameron

26 papers receiving 738 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

European Stroke Organisation (ESO) expedited recommendation on tenecteplase for acute ischaemic stroke

2023 88 citations Sonia Alamowitch, Guillaume Turc et al. European Stroke Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alan C. Cameron United Kingdom	12	311	247	155	131	126	31	756
Séan Murphy Ireland	17	222 0.7×	413 1.7×	298 1.9×	116 0.9×	39 0.3×	52	955
Oğuz Karahan Türkiye	15	219 0.7×	72 0.3×	145 0.9×	58 0.4×	85 0.7×	76	622
Wentao Wu China	7	93 0.3×	218 0.9×	149 1.0×	242 1.8×	275 2.2×	17	874
Patrick Ffrench France	18	208 0.7×	271 1.1×	351 2.3×	133 1.0×	64 0.5×	50	1.2k
Christina Steger Austria	11	360 1.2×	226 0.9×	97 0.6×	95 0.7×	33 0.3×	33	634
Christiane Engelbertz Germany	15	288 0.9×	82 0.3×	166 1.1×	78 0.6×	39 0.3×	47	730
Erol Arslan Türkiye	16	129 0.4×	120 0.5×	92 0.6×	194 1.5×	78 0.6×	52	826
Małgorzata Konieczyńska Poland	16	255 0.8×	109 0.4×	217 1.4×	86 0.7×	42 0.3×	59	769
Kenichi Matsushita Japan	18	464 1.5×	132 0.5×	154 1.0×	390 3.0×	91 0.7×	90	1.2k

Countries citing papers authored by Alan C. Cameron

Since Specialization

Citations

This map shows the geographic impact of Alan C. Cameron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan C. Cameron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan C. Cameron more than expected).

Fields of papers citing papers by Alan C. Cameron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan C. Cameron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan C. Cameron. The network helps show where Alan C. Cameron may publish in the future.

Co-authorship network of co-authors of Alan C. Cameron

This figure shows the co-authorship network connecting the top 25 collaborators of Alan C. Cameron. A scholar is included among the top collaborators of Alan C. Cameron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan C. Cameron. Alan C. Cameron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Romoli, Michele, António Toscano, Paolo Eusebi, et al.. (2025). Risk of Recurrent Stroke, Mortality, and Intracerebral Hemorrhage in Patients With Atrial Fibrillation Detected Before or After a Stroke. Neurology. 104(6). e213426–e213426. 1 indexed citations

Sposato, Luciano A., Alan C. Cameron, Michelle C. Johansen, et al.. (2024). Ischemic stroke prevention in patients with atrial fibrillation and a recent ischemic stroke, TIA, or intracranial hemorrhage: A World Stroke Organization (WSO) scientific statement. International Journal of Stroke. 20(4). 385–400. 1 indexed citations

Cameron, Alan C., et al.. (2024). Impact of European Stroke Organisation secondary prevention guideline for ischaemic stroke / transient ischaemic attack. Journal of Stroke and Cerebrovascular Diseases. 33(12). 108034–108034.

Alamowitch, Sonia, Guillaume Turc, Lina Palaiodimou, et al.. (2023). European Stroke Organisation (ESO) expedited recommendation on tenecteplase for acute ischaemic stroke. European Stroke Journal. 8(1). 8–54. 88 indexed citations breakdown →

Cameron, Alan C. & Azmil H. Abdul‐Rahim. (2023). The Optimal Management for People with Acute Stroke and Minor Deficits: Intravenous Thrombolysis or Medical Management?. Thrombosis and Haemostasis. 123(7). 666–668. 1 indexed citations

Vail, Andy, Alan C. Cameron, Mira Katan, et al.. (2022). Molecular biomarkers predicting newly detected atrial fibrillation after ischaemic stroke or TIA: A systematic review. European Stroke Journal. 8(1). 125–131. 4 indexed citations

Cameron, Alan C., et al.. (2022). Improving detection and management of atrial fibrillation after ischaemic stroke in Glasgow (IMPROVE-AF): A quality improvement project. The Journal of the Royal College of Physicians of Edinburgh. 52(3). 213–219. 1 indexed citations

Cameron, Alan C., Markus Arnold, Kieran F. Docherty, et al.. (2022). Preventing Recurrent Cardioembolic Stroke: Right Approach, Right Patient (PRECISE) Study Protocol. Cerebrovascular Diseases. 52(2). 123–129.

Gill, Dipender, Alan C. Cameron, Stephen Burgess, et al.. (2020). Urate, Blood Pressure, and Cardiovascular Disease. Hypertension. 77(2). 383–392. 91 indexed citations

10.

Quinn, Terence J., et al.. (2020). The impact of atrial fibrillation type on the risks of thromboembolic recurrence, mortality and major haemorrhage in patients with previous stroke: A systematic review and meta-analysis of observational studies. European Stroke Journal. 5(2). 155–168. 10 indexed citations

11.

Cameron, Alan C., Karla B Neves, Francisco J. Rios, et al.. (2020). Comprehensive Characterization of the Vascular Effects of Cisplatin-Based Chemotherapy in Patients With Testicular Cancer. JACC CardioOncology. 2(3). 443–455. 23 indexed citations

12.

Abdul‐Rahim, Azmil H., Alan C. Cameron, Janika Kõrv, et al.. (2020). The Incidence and Associated Factors of Early Neurological Deterioration After Thrombolysis. Stroke. 51(9). 2705–2714. 45 indexed citations

13.

Morrow, Andrew, Alan C. Cameron, Alexander R. Payne, Jeff White, & Ninian N. Lang. (2019). Cisplatin related cardiotoxicity – acute and chronic cardiovascular morbidity in a testicular cancer survivor. Scottish Medical Journal. 65(1). 24–27. 4 indexed citations

14.

Dobbin, Stephen J.H., Alan C. Cameron, Mark C. Petrie, et al.. (2018). Toxicity of cancer therapy: what the cardiologist needs to know about angiogenesis inhibitors. Heart. 104(24). 1995–2002. 51 indexed citations

15.

Robertson, Louise, et al.. (2018). Each baby counts in 2018 – lessons learned and future directions. Obstetrics Gynaecology & Reproductive Medicine. 28(8). 253–257. 6 indexed citations

16.

Cameron, Alan C., Azmil H. Abdul‐Rahim, Niaz Ahmed, et al.. (2017). Professional guideline versus product label selection for treatment with IV thrombolysis: An analysis from SITS registry. European Stroke Journal. 3(1). 39–46. 5 indexed citations

17.

Cameron, Alan C., Ninian N. Lang, & Rhian M. Touyz. (2016). Drug Treatment of Hypertension: Focus on Vascular Health. Drugs. 76(16). 1529–1550. 58 indexed citations

18.

Cameron, Alan C., Rhian M. Touyz, & Ninian N. Lang. (2015). Vascular Complications of Cancer Chemotherapy. Canadian Journal of Cardiology. 32(7). 852–862. 158 indexed citations

19.

Cameron, Alan C., et al.. (2008). The Burden of Atrial Fibrillation in Unselected Acute Medical Admissions. Scottish Medical Journal. 53(2). 42–47. 2 indexed citations

20.

Cameron, Alan C., et al.. (1997). Prenatal Diagnosis and Management of Urethral Obstruction. Journal of obstetrics and gynaecology research. 23(1). 59–62. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact